Sexual Dysfunction, Depression, and the Impact of Antidepressants

@article{Kennedy2009SexualDD,
  title={Sexual Dysfunction, Depression, and the Impact of Antidepressants},
  author={S. Kennedy and S. Rizvi},
  journal={Journal of Clinical Psychopharmacology},
  year={2009},
  volume={29},
  pages={157-164}
}
  • S. Kennedy, S. Rizvi
  • Published 2009
  • Psychology, Medicine
  • Journal of Clinical Psychopharmacology
Sexual dysfunction is a common symptom of depression. Although decreased libido is most often reported, difficulties with arousal, resulting in vaginal dryness in women and erectile dysfunction in men, and absent or delayed orgasm are also prevalent. Sexual dysfunction is also a frequent adverse effect of treatment with most antidepressants and is one of the predominant reasons for premature drug discontinuation. Selective serotonin reuptake inhibitors are the most widely prescribed… Expand
Management of antidepressant-induced sexual dysfunction
  • N. Keks, J. Hope, C. Culhane
  • Psychology, Medicine
  • Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists
  • 2014
TLDR
The preponderance of evidence suggests that antidepressant s can be divided into high risk and low risk categories with regard to propensity for antidepressant-induced sexual dysfunction, although there is disagreement about mirtazapine and methodological issues militate against definitive findings. Expand
Sexual dysfunction related to psychotropic drugs: a critical review--part I: antidepressants.
TLDR
There is consistent evidence to suggest that antidepressant medication adversely affects one or more of the 3 phases of sexual response (desire, arousal and orgasm) and Clinicians must be aware of drug-induced sexual dysfunction. Expand
Sexual dysfunction associated with major depressive disorder and antidepressant treatment
TLDR
A review of available information regarding SD related to both depression and antidepressant treatment, including literature up to June 2014, suggests that bupropion and newer antidepressants exhibit a more favorable SD profile compared with other antidepressants, especially selective serotonin reuptake inhibitors. Expand
Psychiatric disorders and sexual dysfunction.
  • M. Waldinger
  • Psychology, Medicine
  • Handbook of clinical neurology
  • 2015
TLDR
Psychiatrists and other doctors need to take the initiative to talk about the patient's sexual life in order to become informed about potential medication-induced sexual difficulties, and research into psychotropic-inducedSexual side-effects suffers from substantial methodologic limitations. Expand
Assessment and management of sexual dysfunction in the context of depression
TLDR
A concise, evidence-based schematic is presented to assist physicians in minimizing treatment-emergent sexual dysfunction (TESD) while treating depression. Expand
Psychotropic-induced sexual dysfunction
Psychotropic-induced sexual dysfunction is a common and bothersome side effect of psychotropic medications. The majority of information available on the subject primarily pertains to antidepressants,Expand
Sexual Dysfunction in Women with Depressive Disorder: A Prospective, Hospital Based Study
TLDR
Women with depression have a high prevalence of sexual dysfunction and despite the improvement in sexual dysfunctions, the individual domains of sexual functions were not comparable to the normal subjects at the end of 6 weeks suggesting the need for longer treatment. Expand
Sexual functioning in females with depression in remission receiving escitalopram
TLDR
A significant proportion of sexually active females with depression currently in remission, receiving escitalopram, reported dysfunction in all domains of sexual function; thus, routine screening for sexual dysfunction during follow up is advisable for early identification and prompt treatment. Expand
Gender difference in antidepressant-related sexual dysfunction in Taiwan.
TLDR
Depression and antidepressants may have different impacts on the sexual function of males and females. Expand
Female sexual dysfunction in patients treated with antidepressant-comparison between escitalopram and fluoxetine.
TLDR
There was no significant difference in the risk of having FSD between patients treated with fluoxetine or escitalopram as defined in the fourth edition of Diagnostic and Statistical Manual of Mental Disorders. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 124 REFERENCES
Sexual dysfunction before antidepressant therapy in major depression.
TLDR
While age at onset of depression and number of prior episodes showed a modest correlation with SD measures, there were no correlations with severity of depression or specific symptoms clusters. Expand
Depression and sexual dysfunction.
TLDR
There is a need for further studies of the effects of antidepressants on sexual function, as accurate identification of the incidence of treatment-emergent dysfunction has proved troublesome. Expand
Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation.
TLDR
Comparisons with serotonin reuptake inhibitors have revealed less desire and orgasm dysfunction with nonserotonergic bupropion, lessOrgasm dysfunction with nefazodone, and superior overall satisfaction with sexual functioning with bupropions or nefzodone. Expand
Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder
TLDR
The results suggest that reboxetine may be of particular benefit for patients at risk for sexual dysfunction with SSRIs, and not just for patients diagnosed with major depressive disorder. Expand
Sexual dysfunctions in depression
TLDR
The incidence of sexual dysfunctions in a group of 51 drug-free depressed patients and in age- and sex-matched controls was studied and the genital symptoms correlated inversely with the L (lie) score of the Eysenck Personality Inventory. Expand
Prevalence of sexual dysfunction among newer antidepressants.
TLDR
This is the first study to assess sexual dysfunction across the newer antidepressants using consistent methodology and a validated rating scale and overall, SSRIs and venlafaxine XR were associated with higher rates of sexual dysfunction than bupropion or nefazodone. Expand
Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
TLDR
An unexpected relationship was found between favorable drug response and a decreased level of drug-induced sexual dysfunction in patients treated with sertraline or paroxetine. Expand
Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.
TLDR
Regardless of treatment, patients who achieved remission of MDD showed improvement in global sexual functioning, whereas worsening was observed for patients who did not achieve remission (P < 0.001). Expand
Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.
TLDR
Open-ended questions are an insufficient tool to estimate sexual dysfunction, and premarketing clinical trials should therefore include basic explicit assessments, and the failure to find a correlation between treatment duration and sexual dysfunction adds to the notion that sexual side effects due to SSRIs do not abate over time. Expand
Survey of Treatment Practices for Sexual Dysfunction(s) Associated with Anti-Depressants
TLDR
Switching to another antidepressant, decreasing the dose of an antidepressant, and adding oral agents such as bupropion, phosphodiesterase-5 inhibitors, and some dopaminergic agents are management strategies most frequently used by the experts and the experts consider these strategies as the most effective ones. Expand
...
1
2
3
4
5
...